サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1489302

オルガノイドの世界市場：2033年までの機会と戦略

Organoids Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 309 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
オルガノイドの世界市場：2033年までの機会と戦略
出版日: 2024年06月05日
発行: The Business Research Company
ページ情報: 英文 309 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のオルガノイド市場は2018年に13億605万米ドルと評価され、2023年まで20.00%以上のCAGRで成長しました。

個別化医療に対する需要の増加

個別化医療に対する需要の増加は、オルガノイド市場の成長を促進しました。個別化医療は、精密医療や個別化医療とも呼ばれ、患者一人ひとりの特性に合わせた治療や介入を目指す医療へのアプローチです。個々の患者の特徴を再現する能力を持つオルガノイドは、特定の遺伝子プロファイルや疾患特性に合わせた治療を行う上で不可欠なツールとなっています。この需要の急増は、薬物検査、疾患モデリング、精密医療アプリケーションにおけるオルガノイドの重要性と採用を高めています。例えば、2022年10月、米国を拠点とし、科学者、患者、医療提供者を代表する組織である個別化医療連合（Personalized Medicine Coalition）は、複数のタイプのがん、遺伝的希少疾患、さまざまな慢性疾患や感染症を患う人々のために、75,000を超える遺伝子検査製品と300を超える個別化医薬品が市場に出回っていると推定しています。さらに、個別化医療を提唱する米国の個別化医療連合（PMC）によると、2022年には米国食品医薬品局による新薬承認の34％を個別化医薬品が占めると推定され、過去8年間はいずれも承認の25％以上を個別化医薬品が占めています。従って、個別化医療に対する需要の増加は、歴史的な期間におけるオルガノイド市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • オルガノイド市場定義とセグメンテーション
  • 市場セグメンテーション：製品別
    • 肝臓オルガノイド
    • 大腸オルガノイド
    • 腸管オルガノイド
    • その他
  • 市場セグメンテーション：用途別
    • 発生生物学
    • 感染症の病理学
    • 再生医療
    • 薬物の毒性と有効性の試験
    • 創薬と個別化医療
    • その他
  • 市場セグメンテーション：最終用途産業別
    • 病院と診断センター
    • バイオ医薬品企業
    • 学術機関・研究機関
    • 受託研究機関
  • 市場セグメンテーション：由来別
    • 多能性幹細胞
    • 臓器特異的成体幹細胞

第7章 主要な市場動向

  • バイオ医薬品調査のためのオルガノイドソリューションに焦点を当て、ソリューションを拡大
  • 特殊な3D細胞モデルの作成に向けた生命科学調査の進歩
  • 心臓安全性試験の改善に向けた心臓オルガノイドベースのキットの開発
  • 次世代オルガノイド技術の進歩に向けた戦略的パートナーシップとコラボレーション
  • 高スループットアプリケーション向けのカスタムオルガノイドラインサービスに注力
  • オルガノイドと細胞の採取を迅速化するための3D細胞培養技術の採用増加

第8章 オルガノイド市場：マクロ経済シナリオ

  • COVID-19の影響：オルガノイド市場
  • ウクライナ戦争の影響：オルガノイド市場
  • 高インフレの影響：オルガノイド市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018-2023
    • 市場促進要因、2018-2023
    • 市場抑制要因、2018-2023
  • 市場成長予測、2023-2028, 2033F
    • 市場促進要因、2023-2028
    • 市場抑制要因、2023-2028

第10章 世界のオルガノイド市場：セグメンテーション

  • 世界のオルガノイド市場：製品別、実績と予測、2018-2023, 2028F, 2033F
  • 世界のオルガノイド市場：用途別、実績と予測、2018-2023, 2028F, 2033F
  • 世界のオルガノイド市場：最終用途産業別、実績と予測、2018-2023, 2028F, 2033F
  • 世界のオルガノイド市場：由来別、実績と予測、2018-2023, 2028F, 2033F

第11章 オルガノイド市場：地域・国別分析

  • 世界のオルガノイド市場：地域別、実績と予測、2018-2023, 2028F, 2033F
  • 世界のオルガノイド市場：国別、実績と予測、2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Thermo Fisher Scientific Inc
  • Carl Zeiss AG
  • Corning Incorporated
  • Lonza Group Ltd
  • STEMCELL Technologies Inc

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • Bruker Corporation Acquired Acquifer Imaging
  • Molecular Devices Acquired Cellesce
  • Crown Bioscience International Acquired OcellO

第23章 機会と戦略

  • 世界のオルガノイド市場：新たな機会を提供する国
  • 世界のオルガノイド市場：新たな機会を提供するセグメント
  • 世界のオルガノイド市場：成長戦略

第24章 オルガノイド市場：結論と提言

  • 結論
  • 提言

第25章 付録

目次
Product Code: o&s1233

Organoids are three-dimensional cell cultures that mimic the structural and functional characteristics of real organs. These miniature, simplified versions of organs are grown from stem cells in a laboratory environment to replicate some of the complex biological structures and processes of their full-sized counterparts.

The organoids market consists of sales, by entities (organizations, sole traders and partnerships), of organoids products that are a revolutionary tool in modern biomedical research and medicine, enabling scientists and doctors to study human development, disease progression and drug responses in a controlled and replicable way.

The global organoids market was valued at $1,306.05 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the organoids market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Organoids, with their ability to replicate individual patient characteristics, have become indispensable tools in tailoring medical treatments to specific genetic profiles and disease characteristics. This demand surge has elevated the significance and adoption of organoids in drug testing, disease modeling and precision medicine applications. For instance, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system), estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increase in demand for personalized medicine supported the growth of the organoids market during the historic period.

Advancements In Life Science Research For The Production Of Specialized 3D Cell Models

Companies are focusing on advancements in life science research for the production of specialized 3D organoids, representing a substantial stride in biomedical advancement. These pioneering advancements entail crafting organoids that closely emulate the structural and functional intricacies of human organs, granting researchers an unparalleled understanding of disease mechanisms and drug reactions. For example, in February 2024, Cell Microsystems, a US-based biotechnology company that provides advanced tools for cell biology, announced a strategic partnership with OMNI Life Science (OLS), a Germany-based cell biology company. This collaboration endeavors to launch three groundbreaking products-CERO, CASY and TIGR-into the US and Canadian markets, advancing life science research in North America. The CERO 3D, a pioneering instrument, fosters an ideal cell culture environment for producing specialized 3D cell models, such as stem cells, spheroids, organoids and tissues.

The global organoids market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.50% of the total market in 2022.

Organoids Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application, by end-use industries and by source.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organoids market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application, by end-use industries and by source in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Competitive Benchmarking -Briefs on the financials comparison between major players in the market.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids; Other Organoids
  • 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations
  • 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Hepatic Organoids
    • 6.4.2 Colorectal Organoids
    • 6.4.3 Intestinal Organoids
    • 6.4.4 Other Organoids
  • 6.5 Market Segmentation By Application
    • 6.5.1 Developmental Biology
    • 6.5.2 Disease Pathology Of Infectious Disease
    • 6.5.3 Regenerative Medicine
    • 6.5.4 Drug Toxicity And Efficacy Testing
    • 6.5.5 Drug Discovery And Personalized Medicine
    • 6.5.6 Other Applications
  • 6.6 Market Segmentation by End-Use Industries
    • 6.6.1 Hospitals And Diagnostic Centers
    • 6.6.2 Biopharmaceutical Companies
    • 6.6.3 Academics and Research Institutes
    • 6.6.4 Contract Research Organizations
  • 6.7 Market Segmentation By Source
    • 6.7.1 Pluripotent Stem Cells
    • 6.7.2 Organ-Specific Adult Stem Cells

7 Major Market Trends

  • 7.1 Focus On Organoid Solutions For Biotherapeutic Research And To Expand Solutions
  • 7.2 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
  • 7.3 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing
  • 7.4 Strategic Partnerships And Collaborations To Advance Next-Generation Organoids Technology
  • 7.5 Focus On Custom Organoid Line Services For High-Throughput Applications
  • 7.6 Rising Adoption Of 3D Cell Culture Techniques To Expedite Organoid And Cell Harvesting

8 Organoids Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Organoids Market
  • 8.2 Impact Of The War In Ukraine On The Organoids Market
  • 8.3 Impact Of High Inflation On The Organoids Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Organoids Market Segmentation

  • 10.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Organoids Market, Regional and Country Analysis

  • 11.1 Global Organoids Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Organoids Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Organoids Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Organoids Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Organoids Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Organoids Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Organoids Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Carl Zeiss AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial performance
  • 19.4 Corning Incorporated
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Performance
  • 19.5 Lonza Group Ltd
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 STEMCELL Technologies Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • 22.2 Bruker Corporation Acquired Acquifer Imaging
  • 22.3 Molecular Devices Acquired Cellesce
  • 22.4 Crown Bioscience International Acquired OcellO

23 Opportunities And Strategies

  • 23.1 Global Organoids Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Organoids Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Organoids Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Organoids Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer